Ignite Creation Date:
2024-05-05 @ 10:23 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01092104
Status:
COMPLETED
Last Update Posted:
2013-07-10
First Post:
2010-03-22
Brief Title:
A Proof of Concept Study to Evaluate the Antiviral Activity Safety and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected Antiretroviral Treatment-Experienced CCR5 Antagonist-Naïve Patients
Sponsor:
Tobira Therapeutics Inc
Organization:
Tobira Therapeutics Inc
Organization Data
Organization:
Tobira Therapeutics Inc
Class:
INDUSTRY
Study ID:
652-2-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tobira Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None